Maylyn Martinez, MD, MSc is a clinician-scientist in the section of Hospital Medicine. Her research focuses on understanding the clinical, demographic, and psychosocial variables that contribute to the risk for hospital-acquired disability (HAD) and functional decline. She uses this information to inform the development of tools (e.g., predictive algorithms, artificial intelligence/machine learning, clinical decision support) to triage hospitalized patients for rehabilitation with physical and occupational therapists for the treatment and prevention of HAD. Her related health disparities work centers on understanding differences by race and neighborhood-level social disadvantage in functional outcomes for hospitalized patients and in the utilization of acute and post-acute physical rehabilitation for HAD treatment and prevention.
As a clinician-scientist, Dr. Martinez has published numerous articles and lectured at national scientific meetings. Her work was selected for the Top 10 Articles in Hospital Medicine in 2022 by the Society for General internal Medicine. Other honors include the best clinical abstract at the 2020 Janet Rowley Department of Medicine Research Day, a fellowship with SGIM's Unified Leadership Training for Diversity Leadership Program, and being chosen to serve on numerous local and national committees and editorial boards.
University of Chicago
Chicago, IL
MScP
2022
University of California, Irvine
Orange, CA
- Chief Residency
2019
University of California, Irvine
Orange, CA
- Internal Medicine
2018
Northwestern University
Chicago, IL
M.D.
2015
Deconditioned, disabled, or debilitated? Formalizing management of functional mobility impairments in the medical inpatient setting.
Deconditioned, disabled, or debilitated? Formalizing management of functional mobility impairments in the medical inpatient setting. J Hosp Med. 2022 10; 17(10):843-846.
PMID: 35818341
The Effect of Redeployment During the COVID-19 Pandemic on Development of Anxiety, Depression, and Insomnia in Healthcare Workers.
The Effect of Redeployment During the COVID-19 Pandemic on Development of Anxiety, Depression, and Insomnia in Healthcare Workers. J Gen Intern Med. 2022 03; 37(4):1003-1005.
PMID: 34981365
Defining Potential Overutilization of Physical Therapy Consults on Hospital Medicine Services.
Defining Potential Overutilization of Physical Therapy Consults on Hospital Medicine Services. J Hosp Med. 2021 Aug 18.
PMID: 34424191
Sleep Disturbances in Frontline Health Care Workers During the COVID-19 Pandemic: Social Media Survey Study.
Sleep Disturbances in Frontline Health Care Workers During the COVID-19 Pandemic: Social Media Survey Study. J Med Internet Res. 2021 05 19; 23(5):e27331.
PMID: 33875414
Rethinking Hospital-Associated Disability for Patients With COVID-19.
Rethinking Hospital-Associated Disability for Patients With COVID-19. J Hosp Med. 2020 12; 15(12):757-759.
PMID: 33231543
Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin.
Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin. Clin Cancer Res. 2015 Mar 01; 21(5):1161-71.
PMID: 25542900
Xanthine oxidase-derived ROS upregulate Egr-1 via ERK1/2 in PA smooth muscle cells; model to test impact of extracellular ROS in chronic hypoxia.
Xanthine oxidase-derived ROS upregulate Egr-1 via ERK1/2 in PA smooth muscle cells; model to test impact of extracellular ROS in chronic hypoxia. PLoS One. 2011; 6(11):e27531.
PMID: 22140445